Business
Why the Orthocell (ASX:OCC) share price has popped 6% today
The Orthocell Ltd (ASX: OCC) share price is surging higher today. This comes after the biotechnology company received Australian market approval for its CelGro product. CelGro is a collagen scaffold that supports tissue reconstruction and repair, with a wide range of uses in orthopaedics, general, gynaecology and ENT surgeries.
At the time of writing, the Orthocell share price is up 6% to 43.5 cents.
What’s moving the Orthocell share price?
Investors appear to be pleased with the latest news from the company, pushing the Orthocell share price higher.
With the latest approval, Orthocell can now begin to supply and market CelGro in dental bone and tissue regeneration procedures. According to the company, the CelGro device provides…
-
General14 hours agoGoldfields man in coma after allegedly smashing head into ambulance windscreen
-
Business22 hours agoShould we be paying more attention to these two rocketing ASX small-cap mining stocks?
-
Noosa News24 hours agoHealth regulator accused of failing to support patients amid complaints over doctors’ conduct
-
Noosa News17 hours agoQueensland Museum faces criticism over Shell sponsorship of climate change education materials